- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01225458
Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE) (BCDE)
The trial is a multicenter, prospective, randomized, open study. A total of 500 elderly patients aged over 75 years with renal insufficiency stage 5 will be included in the study after signed informed consent. Patients will be randomized 1/1 in two arms : 250 patients in the "exclusive nephrology follow-up" arm will continue their usual follow-up; 250 patients in the "geriatric follow-up" arm will have both their usual nephrology follow-up and a geriatric follow-up.
The aim of the study is to determine if a systematized gerontologist evaluation delay the occurrence of a composite primary endpoint : death, dementia, depression and severe dependency. The hypothesis is that the functional and vital prognosis of a patient with renal insufficiency depends not only on common and classical factors but also on cognitive and psychological functions and dependence, particularly in elderly patients.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Nice, France, 06000
- CHU de Nice
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion criteria :
- Patients aged of 75 years old or more,
- Chronic kidney disease stage 5 defined by :
- either an estimated GFR (MDRD) ≤ 15ml/mn/1,73 m² in a non-dialysis patient with a nephrology follow-up > 3 months ("Pre-dialysis cohort"),
- or a dialysis treatment started for more than 3 months and less than one year, after a pre-dialysis follow-up > 3 months ("post-dialysis cohort"),
- Signed and dated informed consent.
Exclusion criteria :
- Moderately severe to severe dementia (MMS ≤ 15),
- Major depression and/or GDS-15 > 10/15,
- Severe dependency (ADL < 3/6).,
- Psychosis, mutism or aphasia,
- Malignancy or any pathology with life expectancy < one year.
- Ongoing specialized geriatric care
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur placebo: exclusive nephrology follow-up
250 patients will be included and randomized in the "exclusive nephrology follow-up" arm will continue their usual nephrology follow-up with consultations every 6 months during 3 years for dialysis patients or with consultations every 6 months before dialysis, 3 months after starting dialysis and every 6 months for a total duration of 3 years for non-dialysis patients.
In addition to their nephrology consultations, patients will benefit from a geriatric evaluation with MMS, GDS and ADL scoring.
|
Geriatric evaluation with MMS, GDS and ADL scoring
evaluation of cognitive functions, psychological functions, dependency in activities, vision, audition, mobility and nutritional status : only at the first visit
|
Expérimental: geriatric follow-up
250 patients will be included and randomized in the "geriatric follow-up" arm. They will continue their usual nephrology follow-up with consultations every 6 months during 3 years for dialysis patients or with consultations every 6 months before dialysis, 3 months after starting dialysis and every 6 months for a total duration of 3 years for non-dialysis patients. About geriatric evaluation Patients randomized in this arm will also have more complete tests to evaluate cognitive functions (memory, language and movements), psychological functions (depression and anxiety) and dependency in activities of daily living. Other tests will allow evaluate vision, audition, mobility and nutritional status. |
Geriatric evaluation with MMS, GDS and ADL scoring
evaluation of cognitive functions, psychological functions, dependency in activities, vision, audition, mobility and nutritional status : only at the first visit
evaluation of cognitive functions, psychological functions, dependency in activities, vision, audition, mobility and nutritional status : every 6 month for 3 years
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
death
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
occurrence of a severe dementia (MMS < 10)
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
major depression detected by GDS-15 > 10/15 and confirmed by DSM-IV criteria
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
severe dependency (ADL < 3/6)
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
cognitive, psychic and autonomy scores
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
cardiovascular morbidity and mortality
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
bone fracture
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
nutritional parameters
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
dialysis parameters
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
biological follow-up of chronic kidney disease including haemoglobin level
Délai: every 6 month for 3 years since inclusion
|
every 6 month for 3 years since inclusion
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- BCDE
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur shorter tests
-
Swiss Paraplegic Centre NottwilRecrutementEnquête sur les caractéristiques optimales d'entraînement FES après une lésion de la moelle épinièreLésion de la moelle épinièreSuisse
-
Duke UniversityRetiré
-
Sheffield Hallam UniversitySheffield Teaching Hospitals NHS Foundation TrustComplétéSclérose en plaquesRoyaume-Uni
-
University of SydneyInconnue
-
Boston UniversityNational Institute of Mental Health (NIMH)Actif, ne recrute pasVIH/SIDA | La violenceAfrique du Sud
-
Koç UniversityPas encore de recrutementQualité de vie | Incontinence, Urgence | Incontinence Stress
-
University of PlymouthUniversity Hospital Plymouth NHS Trust; Royal Cornwall Hospitals TrustComplétéDouleur à la ceinture pelvienneRoyaume-Uni
-
University of MichiganActif, ne recrute pasPerte osseuse, alvéolaireÉtats-Unis
-
Cairo UniversityInconnueTroubles de l'articulation temporo-mandibulaireEgypte
-
Mansoura UniversityComplétéTransplantation hépatique